Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2015 1
2016 2
2018 1
2019 3
2020 1
2021 3
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
Cheema PK, Banerji SO, Blais N, Chu QS, Juergens RA, Leighl NB, Sacher A, Sheffield BS, Snow S, Vincent M, Wheatley-Price PF, Yip S, Melosky BL. Cheema PK, et al. Curr Oncol. 2023 Jul 6;30(7):6473-6496. doi: 10.3390/curroncol30070476. Curr Oncol. 2023. PMID: 37504336 Free PMC article.
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Melosky B, Cheema P, Agulnik J, Albadine R, Bebb DG, Blais N, Burkes R, Butts C, Card PB, Chan AMY, Hirsh V, Ionescu DN, Juergens R, Morzycki W, Poonja Z, Sangha R, Tehfe M, Tsao MS, Vincent M, Xu Z, Liu G. Melosky B, et al. Curr Oncol. 2018 Oct;25(5):317-328. doi: 10.3747/co.25.4379. Epub 2018 Oct 31. Curr Oncol. 2018. PMID: 30464681 Free PMC article. Review.
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack Years.
Silver A, Ho C, Ye Q, Zhang J, Janzen I, Li J, Martin M, Wu L, Wang Y, Lam S, MacAulay C, Melosky B, Yuan R. Silver A, et al. Curr Oncol. 2023 Jun 8;30(6):5546-5559. doi: 10.3390/curroncol30060419. Curr Oncol. 2023. PMID: 37366902 Free PMC article. Clinical Trial.
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
Melosky B, Cheema P, Juergens RA, Leighl NB, Liu G, Wheatley-Price P, Sacher A, Snow S, Tsao MS, McLeod D, Chu Q. Melosky B, et al. Ther Adv Med Oncol. 2021 Nov 15;13:17588359211056306. doi: 10.1177/17588359211056306. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34804219 Free PMC article. Review.
BACKGROUND: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall survival is suboptimal due to the high metastatic potential of early-stage NSCLC and there is substantial clinical need for additional efficac …
BACKGROUND: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall su …
Canadian Consensus Recommendations on the Management of MET-Altered NSCLC.
Cheema PK, Banerji SO, Blais N, Chu QS, Desmeules P, Juergens RA, Leighl NB, Sheffield BS, Wheatley-Price PF, Melosky BL. Cheema PK, et al. Curr Oncol. 2021 Nov 9;28(6):4552-4576. doi: 10.3390/curroncol28060386. Curr Oncol. 2021. PMID: 34898564 Free PMC article.
22 results